News Alpha Cognition Inc.

Equities

ACOG

CA02074J2048

Market Closed - Canadian Securities Exchange Other stock markets 12:56:08 18/05/2024 am IST			5-day change	1st Jan Change
0.72 ^CAD	0.00%		+5.88%	+9.09%

15/05	Alpha Cognition Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04/04	Alpha Cognition's Q4 Comprehensive Loss Widens A Bit From Year Earlier Period	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alpha Cognition Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05	CI
Alpha Cognition's Q4 Comprehensive Loss Widens A Bit From Year Earlier Period	04/04	MT
Alpha Cognition Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04/04	CI
Alpha Cognition to Present at the Life Science Investor Forum March 7th	01/03	AQ
Alpha Cognition Files U.S. Patent Application Covering an ALPHA-1062 Oral Formulation to Treat Mild to Moderate Alzheimer’s Disease	22/02	BU
Alpha Cognition Inc. Files Composition-Of-M Matter Patent	22/02	CI
Alpha Cognition Provides Business Update	12/02	BU
Alpha Cognition Announces Final Closing of Private Placement Offering and Completion of the Overallotment	20/01	BU
Alpha Cognition Inc. announced that it has received $8.45 million in funding	19/01	CI
Alpha Cognition Announces Fourth Closing of Private Placement and Continuation of the Offering	23/12	BU
Alpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer's disease	08/12	AQ
Alpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer’s Disease	08/12	BU
Alpha Cognition Inc. Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-To-Moderate Alzheimer's Disease	08/12	CI
Alpha Cognition Reports Amended Terms of Private Placement, Continuation of the Offering	05/12	MT
Alpha Cognition Announces Amended Terms of Private Placement and Continuation of the Offering	05/12	BU
Alpha Cognition Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29/11	CI
Alpha Cognition Announces Third Closing of Private Placement and Continuation of the Offering	09/11	BU
Alpha Cognition Announces Second Closing of Private Placement and Continuation of the Offering	17/23/17	BU
Canadian Investment Regulatory Organization Trading Halt - ACOG.WT	03/23/03	AQ
Alpha Cognition Inc. Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer?s Disease	28/23/28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Alpha Cognition Inc.

Equities

ACOG

CA02074J2048

Summary

Filters